Belvedere Trading LLC Gritstone Bio, Inc. Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$1.77 - $4.34 $44,487 - $109,081	-25,134 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$4.03 - $12.19 $12,988 - $39,288	3,223 Added 14.71%	25,134 $85,000
Q4 2021 Jan 25, 2022	BUY	$8.76 - $13.71 $22,075 - $34,549	2,520 Added 13.0%	21,911 $110,000
Q3 2021 Oct 19, 2021	BUY	$6.41 - $13.54 $124,296 - $262,554	19,391 New	19,391 $175,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.